Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria: a Prospective, Multicenter Cohort Study

NCT06469229 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06469229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria: a Prospective, Multicenter Cohort Study
Lead sponsor
Changhai Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2024
Completion date
December 31, 2027
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria, renal pelvis cancer, ureter cancer, urothelial carcinoma